全文获取类型
收费全文 | 10751篇 |
免费 | 963篇 |
国内免费 | 163篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 184篇 |
妇产科学 | 70篇 |
基础医学 | 1279篇 |
口腔科学 | 204篇 |
临床医学 | 939篇 |
内科学 | 1977篇 |
皮肤病学 | 61篇 |
神经病学 | 619篇 |
特种医学 | 414篇 |
外科学 | 916篇 |
综合类 | 1309篇 |
预防医学 | 1867篇 |
眼科学 | 124篇 |
药学 | 1097篇 |
4篇 | |
中国医学 | 445篇 |
肿瘤学 | 263篇 |
出版年
2023年 | 266篇 |
2022年 | 318篇 |
2021年 | 668篇 |
2020年 | 502篇 |
2019年 | 552篇 |
2018年 | 497篇 |
2017年 | 426篇 |
2016年 | 336篇 |
2015年 | 445篇 |
2014年 | 816篇 |
2013年 | 853篇 |
2012年 | 675篇 |
2011年 | 696篇 |
2010年 | 612篇 |
2009年 | 580篇 |
2008年 | 524篇 |
2007年 | 440篇 |
2006年 | 356篇 |
2005年 | 299篇 |
2004年 | 246篇 |
2003年 | 237篇 |
2002年 | 180篇 |
2001年 | 183篇 |
2000年 | 118篇 |
1999年 | 112篇 |
1998年 | 92篇 |
1997年 | 90篇 |
1996年 | 64篇 |
1995年 | 65篇 |
1994年 | 75篇 |
1993年 | 57篇 |
1992年 | 61篇 |
1991年 | 32篇 |
1990年 | 37篇 |
1989年 | 21篇 |
1988年 | 35篇 |
1987年 | 17篇 |
1986年 | 22篇 |
1985年 | 24篇 |
1984年 | 25篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 11篇 |
1979年 | 16篇 |
1976年 | 18篇 |
1974年 | 17篇 |
1973年 | 17篇 |
1972年 | 22篇 |
1971年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
目的:探讨血化瘀方联合针灸治疗对脑梗后遗症患者脑血管血液流变动力学及神经功能的影响。方法:选取2016年1月至2017年1月沈阳市第二中医医院收治脑梗后遗症患者120例作为研究对象,对照组61例患者接受针灸治疗;观察组59例患者接受活血化瘀方联合针灸治疗。2组连续治疗30 d。比较2组患者脑血流流变学指标、神经功能评分、中医证候积分、临床疗效。结果:治疗前2组患者脑部平均血流速度、左侧椎动脉血流量、右侧椎动脉血流量、基底动脉血流量比较,差异无统计学意义(P 0. 05)。治疗后观察组患者脑部平均血流速度、左侧椎动脉血流量、右侧椎动脉血流量、基底动脉血流量大于对照组(P 0. 05)。治疗前2组患者NIHSS评分、MMSE评分比较,差异无统计学意义(P 0. 05)。治疗后观察组患者NIHSS评分显著低于对照组,MMSE评分高于对照组(P 0. 05)。治疗前2组患者头晕目眩、语言謇涩、半身不遂、患侧麻木、舌苔白腻证候评分比较,差异无统计学意义(P 0. 05)。治疗后研究患者头晕目眩、语言謇涩、半身不遂、患侧麻木、舌苔白腻证候评分显著低于对照组(P 0. 05)。2组患者临床疗效比较,差异有统计学意义(Z=-5. 626,P=0. 000)。结论:活血化瘀方联合针灸能改善脑梗后遗症患者脑血管血液流变动力学指标,保护神经功能。 相似文献
43.
44.
45.
46.
47.
《Diagnostic and interventional imaging》2020,101(9):547-553
PurposeTo determine inter-reader agreement in categorizing hepatocellular carcinoma (HCC) treated with locoregional therapy using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm.Materials and methodsA total of 93 patients with a total of 112 HCC nodules that were treated using thermal ablation or transarterial chemoembolization were prospectively included. There were 79 men and 14 women with a mean age of 55 ± 2.6 (SD) years (range: 48–63 years). All patients underwent magnetic resonance imaging (MRI) examination of the liver and MR images were analyzed by two independent observers. Treated HCC nodules were categorized into four groups according to LR-TR scoring system including: (i) LR-TR non-evaluable (treated, response not evaluable); (ii) LR-TR nonviable (treated, probably or definitively not viable); (iii) LR-TR equivocal (treated, equivocally viable) and (iv) LR-TR viable (treated, probably or definitively viable). The inter-observer agreement in LR-TR categorization was assessed using the kappa statistics.ResultsThere was excellent inter-observer agreement between the two reviewers for overall treated HCC according to LR-TR algorithm (kappa = 0.938; 95% CI: 0.89–1.00; P = 0.001) with 97.31% agreement. The LR-TR categories by both reviewers were non-viable (77/112; 69.6% and 76/112; 67.9%), viable (30/112; 26.8% and 32/112; 27.7%) and equivocal (5/112; 4.4% and 4/112; 3.6%). There was excellent inter-observer agreement for LR-TR nonviable (kappa = 0.938; 95% CI: 0.87–1.0; P = 0.001) with 97.3% agreement, LR-TR viable (kappa = 0.955; 95% CI: 0.89–1.00; P = 0.001) with 98.2% agreement and good inter-observer agreement for LR-TR equivocal (kappa = 0.700; 95% CI: 0.28–1.0; P = 0.001) with 97.3% agreement.ConclusionLR-TR algorithm conveys high degrees of inter-observer agreement for the evaluation of treatment response of HCC after thermal ablation and transarterial chemoembolization. 相似文献
48.
49.
50.
Moustapha E. Moustapha Mehnaz Kamal Rania M. Elgamal 《Saudi Pharmaceutical Journal》2020,28(11):1301-1308
Risedronate is a nitrogen-containing bisphosphonate for the treatment and prevention of postmenopausal osteoporosis. The current work aims to develop a novel green HPLC-UV method for the rapid analysis of risedronate sodium in bulk and tablet formulation. The analyzed samples were separated on Waters Atlantis dC18 (150 mm × 3.9 mm; 5 μm) column using a green mobile phase consisting of potassium phosphate buffer pH 2.9 and potassium edetate buffer pH 9.5 in a ratio of 1:2, the final pH was adjusted to 6.8 with phosphoric acid, the mobile phase was pumped at a rate of 1.0 mL/min, with column temperature set at 30 °C, eluted samples were detected at 263 nm and the chromatographic run time was 3.0 min. The method was found to be linear over the concentration range of 14–140 μg/mL with a correlation coefficient (r2) of 0.9994. Accuracy and precision were evaluated from three QC samples (LQC, MQC and HQC) together with the five calibrators where the percentage accuracy was found to be 101.84%. Processed quality control samples of risedronate sodium were tested for stability at different conditions, short term, long term and freeze- thaw stability. The current method was further extended to study the content uniformity of Actonel® tablets following United States Pharmacopoeia (USP) guidelines. The proposed method was fully validated as per ICH guidelines. 相似文献